BA.3.2.* has been shown to be preferentially infecting children.
In the US, this is most apparent in New York (state), which has reported most of the BA.3.2.* samples and also shares Patient age data.
Among children (0-17), BA.3.2.* reached 17% (n=22), vs 2% among adults (n=12), so a ~7X higher rate among children.
🧵

Attached: 1 image Here's the latest variant picture with a global scope, to mid-March. The most interesting development in the last week or two has been the understanding that BA.3.2.* is "Cicada" preferentially infecting children. Here’s the situation for New York (state), from February onwards. Among children (0-17), BA.3.2.* reached 17% (n=22), vs 2% among adults (n=12), so a ~7X higher rate among children. Other states in the US have not reported enough BA.3.2.* samples to draw any conclusions. #COVID19 #SARSCoV2 #Global 🧵